Arcutis Biotherapeutics, Inc.
3 drugs in NADAC|0 Generic,3 Brand
Arcutis Biotherapeutics, Inc. lists 3 NDCs in the CMS NADAC file (0 generic, 3 brand), at an average NADAC of $15.38 per unit, with a week-over-week move of +0.0% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
3
0G / 3B
Avg Price / Unit
$15.3848
$15.38 – $15.40
Avg 7d Change
+0.01%
Across 2 drugs with changes
7d Activity
of 3 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Frequently Asked Questions
How many drugs does Arcutis Biotherapeutics, Inc. make?
Arcutis Biotherapeutics, Inc. lists 3 NDCs in the CMS NADAC file — 0 generic and 3 brand products.
What is the average price of Arcutis Biotherapeutics, Inc. drugs?
The average NADAC across Arcutis Biotherapeutics, Inc.'s portfolio is $15.3848 per unit, ranging from $15.3777 to $15.3969.
What types of drugs does Arcutis Biotherapeutics, Inc. make?
Arcutis Biotherapeutics, Inc. makes drugs across 1 FDA pharmacologic class. The most common by NDC count are Phosphodiesterase 4 Inhibitor (3).
Has Arcutis Biotherapeutics, Inc. had any drug recalls?
No FDA enforcement recalls are matched to Arcutis Biotherapeutics, Inc. in the openFDA feed.
How has Arcutis Biotherapeutics, Inc.'s pricing changed recently?
Over the past 7 days, 1 Arcutis Biotherapeutics, Inc. product rose and 1 fell, with a portfolio-wide average change of +0.0%.
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
ZORYVE 0.15% CREAM roflumilast | $15.3969 per GM | 0.00% |
ZORYVE 0.3% CREAM roflumilast | $15.3798 per GM | +0.02% |
ZORYVE 0.3% FOAM roflumilast | $15.3777 per GM | -0.01% |